Tag: Annals of Internal Medicine

New Cedars-Sinai Study Investigates Shifting Trends in GLP-1RA Prescription

sarah JonasResearch Results

Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs)—prescription medications sold under popular drug names like Ozempic and Wegovy—in the United States.

How to talk to patients of color about the COVID-19 vaccine amid hesitancy and mistrust

sarah JonasResearch Results

A new Annals of Internal Medicine editorial co-authored by a University of Chicago Medicine health disparities researcher offers practical tips for clinicians to discuss the COVID-19 vaccine with patients of color who may be hesitant to get vaccinated.

Johns Hopkins Researchers Offer Lessons Learned From Early Covid-19 Patients

sarah JonasResearch Results

Using a combination of demographic and clinical data gathered from seven weeks of COVID-19 patient care early in the coronavirus pandemic, Johns Hopkins researchers today published a “prediction model” they say can help other hospitals care for COVID-19 patients — and make important decisions about planning and resource allocations.